Quantification of Edema Reduction Using Differential Quantitative T2 (DQT2) Relaxometry Mapping in Recurrent Glioblastoma Treated With Bevacizumab
Journal of Neuro-Oncology - Netherlands
doi 10.1007/s11060-011-0638-x
Full Text
Open PDFAbstract
Available in full text
Date
June 25, 2011
Authors
Publisher
Springer Science and Business Media LLC